Genpact (G) is executing a successful shift toward high-value, tech-led services, with Advanced Technology Solutions (ATS) ...

As a potential first-in-class, AI-designed oral GLP-1 receptor agonist (GLP-1RA), MDR-001 represents a breakthrough in drug discovery, demonstrating how AI can reshape traditional R&D pathways and ...

Q2 2025 Earnings Call Transcript September 15, 2025 Dave & Buster’s Entertainment, Inc. misses on earnings expectations.

Elliott Investment Management has amassed a $4bn stake in PepsiCo and set out ways the US group can improve. Should the ...

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.

The executive who leads Intel’s business with the U.S. government said Tuesday that he has “made the difficult decision” to ...

MSU will host a DARPAConnect Regional Pop-Up on Wednesday, Sept. 24, from 8:30 a.m. to 4 p.m. in the Strand Union Building.

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...

The SCSUNAA celebrates alumni achievement at the Bulldog Excellence Awards, honoring Douglas D. Gantt, Renée N. Hamilton, and ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...